Senior insider sale
Chief Financial Officer at DEFINIUM THERAPEUTICS, INC. — senior position signals high conviction
$251.0K
6.39K shares
What this filing means
ROBERTS BRANDI plans to sell 6.39K shares of DEFINIUM THERAPEUTICS, INC. valued at approximately $251.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/25/2026ACC: 0001950047-26-009817
Officer· Chief Financial Officer
Since Feb 2026
6.39K
Shares to sell
$251.0K
Approx. market value
3.38K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting Under a Registered Plan
Services Rendered
9/25/2026
3.38KTotal acquired3.38K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/25/2026 | Restricted Stock Vesting Under a Registered Plan Services Rendered | 3.38K | — |
| Total | 3.38K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
3.01K
Market value
$126.9K
6/25/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
3.38K
Market value
$124.0K
9/25/2026
Total
Units
6.39K
Value
$251.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/25/2026 | 3.01K | $126.9K | — | Completed |
| Planned — Approximate Date | ||||
9/25/2026 | 3.38K | $124.0K | NASDAQ | Planned |
| Total | 6.39K | $251.0K | ||